Skip to content
value.today

Gennao Bio, Inc.

🇺🇸 New York, New York, USABiotechnologyFounded 2020

Formerly Delmab Bio, Inc.

Total raised
$48 M
2 rounds on record
Latest round
$15 M
Nov 2022
First round on record
May 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Gennao Bio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2022$15 MNo. 2$10 to $50 million

Gennao Bio, Inc.: Raise no. 2, Nov 2022

Investors in this round

3 investors had bought by the notice of Dec 8, 2022: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $40 M offered; $25 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series B Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anuj Goswami · Executive Officer · Mr. Goswami is the General Counsel and Secretary of the Issuer.
  • Chris Duke · Executive Officer · Mr. Duke is the Chief Executive Officer and President of the Issuer.
  • Claudine Prowse · Executive Officer · Dr. Prowse is the Chief Financial Officer and Treasurer of the Issuer.
  • Dale Ludwig · Executive Officer · Dr. Ludwig is the Chief Scientific Officer of the Issuer.
  • Joe McIntosh · Executive Officer · Dr. McIntosh is the Chief Medical Officer of the Issuer.
  • Stephen Squinto · Executive Officer, Director, Promoter · Dr. Squinto is the Executive Chairman of the Issuer.
  • Bradley Campbell · Director
  • Craig Gordon · Director
  • Gary Sender · Director
  • Julie Hambleton · Director
  • Peter Thompson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Duke, Chief Executive Officer of the Issuer. Source: SEC Form D, newest notice filed Dec 8, 2022. Read the notice at the SEC.

equitySEC
May 2021$33 MNo. 1$10 to $50 million

Gennao Bio, Inc.: Raise no. 1, May 2021

Investors in this round

7 investors had bought by the notice of Dec 28, 2021: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$33 M of $55 M offered; $23 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anuj Goswami · Executive Officer · Mr. Goswami is the General Counsel and Secretary
  • Chris Duke · Executive Officer · Mr. Duke is the Chief Operating Officer of the Issuer.
  • Claudine Prowse · Executive Officer · Ms. Prowse is the Chief Financial Officer
  • Dale Ludwig · Executive Officer · Mr. Ludwig is the Chief Scientific Officer
  • Stephen Squinto · Executive Officer, Director, Promoter · Dr. Squinto is the Chief Executive Officer, Executive Chairman, President and Treasurer.
  • Bruce Turner · Director
  • Chau Khuong · Director
  • Gary Sender · Director
  • Julie Hambleton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Duke, Chief Operating Officer of the Issuer. Source: SEC Form D and 1 amendment, newest notice filed Dec 28, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Gennao Bio, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2022).

    SEC Form D · Dec 2022

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2022

That is all the official record says: Gennao Bio, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Gennao Bio, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Gennao Bio, Inc.
NameRoleNamed in
Anuj GoswamiMr. Goswami is the General Counsel and Secretary of the Issuer.Dec 2022
Chris DukeMr. Duke is the Chief Executive Officer and President of the Issuer.Dec 2022
Claudine ProwseDr. Prowse is the Chief Financial Officer and Treasurer of the Issuer.Dec 2022
Dale LudwigDr. Ludwig is the Chief Scientific Officer of the Issuer.Dec 2022
Joe McIntoshDr. McIntosh is the Chief Medical Officer of the Issuer.Dec 2022
Stephen SquintoDr. Squinto is the Executive Chairman of the Issuer.Dec 2022
Bradley CampbellDirectorDec 2022
Craig GordonDirectorDec 2022
Gary SenderDirectorDec 2022
Julie HambletonDirectorDec 2022
Peter ThompsonDirectorDec 2022
Stephen SquintoDr. Squinto is the Executive Chairman of the Issuer.Dec 2022
Bruce TurnerDirectorDec 2021
Chau KhuongDirectorDec 2021
Stephen SquintoDr. Squinto is the Executive Chairman of the Issuer.Dec 2022